Orasis Pharmaceuticals
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia. The company's product, CSF-1, is an eye drop that improves the quality of life for people with presbyopia by alleviating the burden of reading glasses. By repurposing existing and well-studied molecules, CSF-1 is designed to be effective and also safe, comfortable, and easy-to-use.
Domain
orasis-pharma.com
Country
United StatesIndustry
Clinical TrialsEmployees
1-10
Last Funding
$68.0M
Founded
2014
Tech Stack (2 technologies)
Frequently Asked Questions
What technologies does Orasis Pharmaceuticals use?+
Orasis Pharmaceuticals uses 2 technologies including Google Font API, Nginx.
What industry is Orasis Pharmaceuticals in?+
Orasis Pharmaceuticals operates in the Clinical Trials industry.
Where is Orasis Pharmaceuticals based?+
Orasis Pharmaceuticals is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026